TP53 and CTNNB1 are two genes that are most prone to mutations in HCC, and have received continuous research attention because of their involvement in events that dominate tumour development and progression (Calderaro et al., 2017; Cancer Genome Atlas Research Network. The gene discussed is TP53; the disease is hepatocellular carcinoma.